Charles River Laboratories International (CRL) Equity Income (2012 - 2016)

Charles River Laboratories International has reported Equity Income for 5 years, with the latest figure at $442000.0 in Q3 2016.

• On a quarterly basis, Equity Income fell 86.36% year-over-year to $442000.0 in Q3 2016; TTM through Sep 2016 was $8.7 million, a 58.05% increase from a year earlier, with the FY2015 full-year figure at $3.8 million, down 58.9% from the prior year.
• Equity Income was $442000.0 for Q3 2016 at Charles River Laboratories International, down from $5.0 million in the prior quarter.
• The five-year high for Equity Income was $6.1 million in Q1 2014, with the low at -$907000.0 in Q2 2015.
• Average Equity Income over 5 years is $1.4 million, with a median of $1.1 million recorded in 2013.
• The sharpest annual moves came in 2014 and 2015: Equity Income soared 6882.22% in 2014, then tumbled 143.69% in 2015.
• Over 5 years, Equity Income stood at -$373000.0 in 2012, then soared by 386.33% to $1.1 million in 2013, then surged by 80.15% to $1.9 million in 2014, then slumped by 88.62% to $219000.0 in 2015, then soared by 101.83% to $442000.0 in 2016.
• The last three Equity Income figures came in at $442000.0 (Q3 2016), $5.0 million (Q2 2016), and $3.1 million (Q1 2016), per Business Quant data.